ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,508, issued on May 13, was assigned to Personalis Inc. (Fremont, Calif.).
"Customized assays for personalized cancer monitoring" was invented by John West (Menlo Park, Calif.), Laurie Goodman (Menlo Park, Calif.) and Richard Chen (Menlo Park, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods and systems for personalized genetic testing of disease in a subject, in particular for identifying and tracking genetic mutations identified in an individual subject to monitor for cancer or for the spread or recurrence of the disease. In some embodiments, custom assays, including custom panels designed to target sequ...